Last Posted: Oct 04, 2019
- Towards precision medicine: interrogating the human genome to identify drug pathways associated with potentially functional, population-differentiated polymorphisms
M Bachtiar et al, The Pharmacogenomics Journal, October 3, 2019 - Pharmacogenomics of drug-induced liver injury (DILI): Molecular biology to clinical applications.
Kaliyaperumal Kalaiyarasi et al. Journal of hepatology 2018 Oct 69(4) 948-957 - Characterizing the pharmacogenome using molecular inversion probes for targeted next-generation sequencing.
Suzuki Oscar et al. Pharmacogenomics 2019 Sep 20(14) 1005-1020 - Pharmacogenomics and Placebo Response in a Randomized Clinical Trial in Asthma.
Wang Rui-Sheng et al. Clinical pharmacology and therapeutics 2019 Sep - The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later.
Relling Mary V et al. Clinical pharmacology and therapeutics 2019 Sep - miRNAs in drug response variability: potential utility as biomarkers for personalized medicine.
Latini Andrea et al. Pharmacogenomics 2019 Sep 20(14) 1049-1059 - Don't think twice it's all right: tamoxifen and CYP2D6 genotyping in the treatment of breast cancer patients.
Damkier Per et al. Pharmacogenomics 2017 Jun 18(8) 753-754 - Effect of CYP2C19 and CYP2D6 genotype on tamoxifen treatment outcome indicates endogenous and exogenous interplay.
Sim Sarah et al. Pharmacogenomics 2018 19(13) 1027-1037 - Genomic markers of resistance to targeted treatments in gastric cancer: potential new treatment strategies.
Raimondi Alessandra et al. Pharmacogenomics 2018 19(13) 1047-1068 - Pharmacogenomic findings from clinical whole exome sequencing of diagnostic odyssey patients.
Cousin Margot A et al. Molecular genetics & genomic medicine 2017 May 5(3) 269-279
No hay comentarios:
Publicar un comentario